MONITORING OF GENE EXPRESSION IN TACROLIMUS-TREATED DE NOVO RENAL ALLOGRAFT RECIPIENTS FACILITATES INDIVIDUALIZED IMMUNOSUPPRESSION - RESULTS OF THE IMAGEN STUDY

被引：0
|
作者：
Sommerer, C. [1 ]
Millan, O. [2 ]
Glander, P. [3 ]
Brunet, M. [2 ]
Guirado Perich, L. [4 ]
Budde, K. [3 ]
Meuer, S. [5 ]
Zeier, M. [1 ]
Giese, T. [5 ]
机构：
[1] Univ Hosp Heidelberg, Nephrol, Heidelberg, Germany
[2] Hosp Clin Barcelona, Pharmacol & Toxicol Lab, Barcelona, Spain
[3] Charite, Nephrol, Berlin, Germany
[4] Fundacio Puigvert Barcelona, Renal Transplant Unit, Barcelona, Spain
[5] Univ Hosp Heidelberg, Immunol, Heidelberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2020年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
S24-03
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study
    Sommerer, Claudia
    Brunet, Merce
    Budde, Klemens
    Millan, Olga
    Guirado Perich, Lluis
    Glander, Petra
    Meuer, Stefan
    Zeier, Martin
    Giese, Thomas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (10) : 3851 - 3862
  • [2] Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients
    Pascual, J.
    Ocana, J.
    Marcen, R.
    Fernandez, A.
    Galeano, C.
    Alarcon, M. C.
    Burgos, F. J.
    Villafruela, J. J.
    Ortuno, J.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2398 - 2399
  • [3] Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
    Masaki Takao
    Takashi Sakai
    Takashi Nishii
    Hideki Yoshikawa
    Shiro Takahara
    Nobuhiko Sugano
    Rheumatology International, 2011, 31 : 165 - 170
  • [4] Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
    Takao, Masaki
    Sakai, Takashi
    Nishii, Takashi
    Yoshikawa, Hideki
    Takahara, Shiro
    Sugano, Nobuhiko
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (02) : 165 - 170
  • [5] NFAT-regulated gene expression in de novo renal allograft recipients
    Sommerer, C.
    Zeier, M.
    Meuer, S.
    Giese, T.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 476 - 476
  • [6] Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A
    Sommerer, Claudia
    Zeier, Martin
    Meuer, Stefan
    Giese, Thomas
    CLINICAL NEPHROLOGY, 2015, 84 (03) : 165 - 172
  • [7] A Novel Formula to Determine Optimal Immunosuppression in Renal Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: Towards Individualized Immunosuppression
    Pankewycz, O.
    Laftavi, M.
    Onan, E.
    Rucker, D.
    Wang, D.
    Bhuta, K.
    Gruessner, R.
    Gruessner, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 668 - 669
  • [8] In Vivo CYP3A Activity Is Significantly Lower in Cyclosporine-Treated as Compared With Tacrolimus-Treated Renal Allograft Recipients
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (03) : 414 - 422
  • [9] Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients
    Kuypers, DRJ
    Claes, K
    Evenepoel, P
    Maes, B
    Vanrenterghem, Y
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 447 - 451
  • [10] MONITORING OF CALCINEURIN INHIBITORS BY NFAT-REGULATED GENE EXPRESSION IN DE NOVO RENAL ALLOGRAFT RECPIENTS
    Sommerer, C.
    Zeier, M.
    Meuer, S.
    Giese, T.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 49 - 49
12345